Statistical Analysis on Determinant Factors Associated with Time to Death of HIV/TB Co-Infected Patients Under HAART at Debre Tabor Referral Hospital: An Application of Accelerated Failure Time-Shared Frailty Models.
Hailegebrael BirhanKenaw Derebe FentawSetegn Muche FentaBezanesh MelesePublished in: HIV/AIDS (Auckland, N.Z.) (2021)
The majority of patients reside in rural area, have poor adherence to treatment, and have low CD4 cell counts. Educational status, WHO clinical stages, adherence status, and hemoglobin levels of patients are all important determinants of HIV/TB co-infected patients' survival. As a result, to improve the survival of HIV/TB co-infected patients at the start of and during some stages of anti-TB treatment, the concerned body, FMOH, in collaboration with Regional Health Bureau, should emphasize the importance of following treatment for HIV/TB co-infected patients with poor adherence status, advanced WHO clinical stages, and a low CD4+ count.
Keyphrases
- antiretroviral therapy
- hiv positive
- mycobacterium tuberculosis
- hiv infected
- hiv testing
- human immunodeficiency virus
- end stage renal disease
- hepatitis c virus
- hiv aids
- ejection fraction
- newly diagnosed
- healthcare
- chronic kidney disease
- men who have sex with men
- south africa
- prognostic factors
- primary care
- public health
- mental health
- type diabetes
- patient reported outcomes
- risk assessment
- patient reported
- cell therapy
- electronic health record